June 18, 2024Open Access

Liquid Biopsy in the Clinical Management of Cancers

View Full Paper

Ask AI

Bookmark

Authors

HYHo Ho YinHong Kong Polytechnic University CSChung Kei SeeHong Kong Polytechnic University KMKan Chau MingHong Kong Polytechnic University

Discussion

Member takes

Implication

Literature review demonstrates the utility of liquid biopsy for disease monitoring in cancer management, highlighting its potential to guide personalized therapy.

Key Points

Circulating tumor DNA and circulating tumor cells enable non-invasive cancer detection, guiding targeted therapy selection and ongoing disease monitoring across diverse malignancies.
Overview of relevant literature assesses next generation sequencing and digital polymerase chain reaction platforms, tracking somatic variants to quantify minimal residual disease.
Standardizing liquid biopsy protocols and diagnostic workflows remains critical, though evaluating tumor heterogeneity continues to advance dynamic, personalized cancer care strategies.

Cite This Study

Yin et al. (2024) studied this question.

synapsesocial.com/papers/68e643e9b6db6435875d5929 https://doi.org/10.20944/preprints202406.1172.v1

View Full Paper

Ask AI

Bookmark

Implication

Literature review demonstrates the utility of liquid biopsy for disease monitoring in cancer management, highlighting its potential to guide personalized therapy.

Liquid Biopsy in the Clinical Management of Cancers

Discussion

Member takes

Implication

Key Points

Cite This Study

Liquid Biopsy in the Clinical Management of Cancers

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider